Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Centrica PLC Earnings Release 2022

Jan 12, 2023

5292_er_2023-01-12_39ba0c90-5272-43a1-b8d3-9022181c8dd1.html

Earnings Release

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

RNS Number : 4616M

Centrica PLC

12 January 2023

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

12 January 2023

Centrica plc

Trading Update

Centrica plc (the "Company") has continued to deliver strong operational performance from its balanced portfolio since its Trading Update on 10 November 2022. Infrastructure asset availability and volumes have remained good, and we delivered incrementally strong optimisation performance.

As a result, we currently expect to report 2022 full year adjusted earnings per share of above 30p. Cash generation has also been good, and we expect 2022 closing net cash to be above £1 billion.

All 2022 reported financial figures remain subject to audit and the Company is due to release its 2022 Preliminary Results on 16 February 2023.

The person responsible for arranging the release of this announcement on behalf of the Company is Raj Roy, the Company Secretary.

ENDS

Enquiries:

Investors and Analysts

T: 01753 494900

E: [email protected]

Media

T: 01784 843000

E: [email protected]

Centrica plc is listed on the London Stock Exchange (CNA)

Registered Office: Millstream, Maidenhead Road, Windsor, Berkshire SL4 5GD

Registered in England & Wales number: 3033654

Legal Entity Identifier number: E26EDV109X6EEPBKVH76

ISIN number: GB00B033F229

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTDBGDBXSBDGXB